Ohio prescription drug transfer limits to take effect Jan. 1
A new rule handed down by the Ohio State Board of Pharmacy limits state residents from transferring a prescription from one pharmacy to another more than once per year.
A new rule handed down by the Ohio State Board of Pharmacy limits state residents from transferring a prescription from one pharmacy to another more than once per year.
Cardinal Health (NYSE:CAH) renewal of a key drug distribution contract with Walgreen Co. earlier this month brings renewed focus on just how heavily reliant Cardinal is on its top two customers. In Cardinal's fiscal 2010, Walgreen (24 percent) and CVS (22 percent) combined for a 46 percent share of revenues. That's up from a combined 43 percent in 2008. Adam Fein, a pharmaceutical industry consultant with Pembroke Consulting, stated on his blog Drug Channels: "The data show a company that's increasingly at the mercy of its two dominant customers."
Among today's current medical news: a window in what India needs to do to get more biologics business, a hope for journalists to pull their weight against "screening madness," hospital drug shortages, big deals in pharma and a review of Medtronic's stock.
Case Western Reserve University has received its largest-ever grant for eye research -- $10 million over five years to study retinal disease.
Surgical device maker Minimally Invasive Devices has raised more than $1.5 million in equity, according to a document filed with the Securities and Exchange Commission.
Helping lead Ohio State's foray into personalized medicine is Dr. Clay Marsh, director of the Center for Personalized Healthcare (CPHC).
Over the past few years, I’ve posted many blogs about the importance of transport standards. Once a transport standard is widely adopted, content will seamlessly flow per Metcalfe’s law. We already have good content standards from X12, HL7, ASTM, and NCPDP. We already have good vocabulary standards from NLM, Regenstrief, IHTSDO and others. […]
Among today's current medical news: Obamacare renamed, new funds and managers in healthcare venture capital, a pair of notable FDA NON-approvals, fresh praise for the CREST study, and Modern Healthcare's looks back at 2010.
As noted elsewhere in the article, the Congressional Budget Office projects mental health parity will raise premiums just 0.4 percent, hardly noticeable amid the typical double-digit increases. In addition, a leading actuary cites “ample” evidence that spending on mental health and substance abuse benefits lowers overall costs. Why didn't a recent Wall Street Journal story reflect that trend?
I always shake my head at a video I've seen during most Browns games. It's a montage of Browns footage and fans, who are often portrayed as hard-hatted manufacturing types. Throwback narratives like that stand in the way of realizing healthcare is an economic and cultural force -- not just in Cleveland, but in cities all over the country: from Duluth, Minnesota, to Wichita, Kansas, to Winston-Salem, North Carolina, where healthcare has caught up to and blown past manufacturing as a local employer.
Pittsburgh-area medical device company Wright Therapy Products is looking to raise $500,000. The company develops compression pumps and other accessories for patients suffering from poor circulation or swelling in their limbs. Wright Therapy also markets its pumps for the treatment of sports injuries that result in swelling.
Mardil, one of the newest companies based in Minnesota, wants to create a new innovative medical device that treats sloppy mitral valves short of doing open-heart surgery. It is trying to raise up to $12 million.
Among today's current medical news: "Death panel" supporters get their way by going stealth; a new blood pressure drug is approved; a key angel investor says startups need to value that early stage cash; and CEOs may never, ever have the same star power as rock stars.
Fears over another death panel controversy caused the Obama administration to break its pledge about open government and try to sneak in a new Medicare reimbursement for physicians to help the elderly write end-of-life directives. But now these latest health reform facts are out and this cynical move to hide their efforts may scuttle the whole effort.
The Christmas week brought tragedy and change: the tragic passing of an important Alzheimer's disease researcher, a change at the top of Medtronic, revelations of an acquisition pending in the neuromodulation device space, and - on a lighter note - douchebags.